Get started
Author

Baris Sergi

Observed name: Sergi, Baris
ORCID: 0000-0002-6379-2362
Observed ORCID: 0000-0002-6379-2362
OpenAlex ID: A5085189969
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes
2023 · Nádia Ribeiro, Ipek Bulut, et al. · Frontiers in Chemistry · 41
PDF
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes
2022 · Nádia Ribeiro, Ipek Bulut, et al. · Journal of Inorganic Biochemistry · 36
PDF
Understanding the Potential In Vitro Modes of Action of Bis(β‐diketonato) Oxovanadium(IV) Complexes
2021 · Baris Sergi, Ipek Bulut, et al. · ChemMedChem · 11
PDF
Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers
2025 · Baris Sergi, Neslihan Yuksel-Catal, et al. · Cell Death and Disease · 5
PDF
Enhanced selectivity towards melanoma cells with zinc( ii )-Schiff bases containing imidazole derivatives
2024 · Leonor Côrte-Real, Baris Sergi, et al. · Dalton Transactions · 5
Understanding the Modes of Action of β-Ketoiminato Iridium(III) Complexes in Cancer Cells
2025 · Tameryn Stringer, Büşra Yildirim, et al. · Inorganic Chemistry · 3
PDF
HDAC6 inhibition reverts docetaxel resistance in castration resistant prostate cancer
2026 · Ipek Bulut, Buse Cevatemre, et al. · Frontiers in Pharmacology
PDF
GLproxScape reconstructs spatial chromatin occupancy landscapes from tiled genomic locus proteomics
2026 · Selahattin Can Ozcan, Baris Sergi, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Works count: 14
Citation count: 101
H-index: 5
I10-index: 3
Year
Topic
Type